Current role
Diana Brainard
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Gilead Sciences, Inc. (GILD)
Source not stated
Current -
Current
-
Start not stated–2024-12-19
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kalaris Therapeutics, Inc. (KLRS) | AlloVir’s Former Chief Executive Officer | $610,638 | $3,028,669 |
| 2023 | Kalaris Therapeutics, Inc. (KLRS) | AlloVir’s Former Chief Executive Officer | $623,432 | $6,056,943 |
| 2022 | Kalaris Therapeutics, Inc. (KLRS) | Chief Executive Officer | $604,992 | $9,205,379 |
| 2021 | Kalaris Therapeutics, Inc. (KLRS) | Chief Executive Officer | $365,000 | $15,136,121 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.